Feb 17, 2026 04:05PM
Jan 28, 2026 09:05AM
Jan 28, 2026 07:01AM
Jan 28, 2026 07:00AM
Jan 20, 2026 07:00AM
Jan 13, 2026 04:06PM
Jan 13, 2026 04:05PM Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
Dec 16, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 29, 2025 04:05PM
Oct 20, 2025 07:00AM
Oct 20, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 8, 2025 07:00AM Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
Sep 25, 2025 04:05PM
Sep 25, 2025 04:05PM
Aug 13, 2025 07:00AM
Jul 30, 2025 04:05PM
Jul 9, 2025 07:00AM
Jun 30, 2025 07:38AM
Jun 25, 2025 04:05PM Glaukos Corporation (GKOS) Announces EU MDR Certification for iStent infinite and Other Leading MIGS Therapies
Jun 25, 2025 04:05PM
Jun 25, 2025 07:00AM
May 13, 2025 07:00AM
May 1, 2025 07:37AM
Apr 30, 2025 04:05PM
Apr 23, 2025 07:00AM
Apr 16, 2025 07:00AM Glaukos Announces the Release of its 2024 Sustainability Report
Apr 9, 2025 07:00AM
Mar 11, 2025 07:00AM
Feb 24, 2025 07:01AM
Feb 24, 2025 07:00AM
Feb 20, 2025 04:05PM
Jan 23, 2025 07:00AM
Jan 14, 2025 04:06PM Glaukos Corporation (GKOS) Announces Positive Clinical Updates for its iDose Sustained-Release Procedural Pharmaceutical Platform
Jan 14, 2025 04:05PM
Dec 23, 2024 07:05AM
Dec 23, 2024 07:00AM
Dec 17, 2024 07:00AM
Nov 8, 2024 07:00AM
Nov 4, 2024 04:05PM
Oct 17, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
Oct 16, 2024 04:05PM
Oct 16, 2024 04:05PM
Oct 14, 2024 07:00AM
Oct 9, 2024 07:00AM
Apr 16, 2024 04:05PM
Dec 14, 2023 07:00AM
Dec 14, 2023 07:00AM Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
Oct 31, 2023 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All